Literature DB >> 18562100

DTNBP1 haplotype influences baseline assessment scores of schizophrenic in-patients.

Chi-Un Pae1, Antonio Drago, Jung-Jin Kim, Ashwin A Patkar, Tae-Youn Jun, Chul Lee, Laura Mandelli, Diana De Ronchi, In-Ho Paik, Alessandro Serretti.   

Abstract

Dysbindin gene (DTNBP1) has been associated with schizophrenia, but literature findings are inconsistent, and further analyses are required. This study is aimed to investigate if a set of DTNBP1 variations might influence clinic psychotic phenotype or treatment response in a sample of 240 Korean schizophrenic in-patients. Four variants have been selected (rs3213207; rs1011313; rs16876759; rs2619522) on the basis of previous findings of association with schizophrenia, bipolar disorder and antidepressant response. Single marker analysis gave marginal results. Haplotype analysis identified a significant association between A-A (rs3213207(A/G), rs1011313(A/G)) haplotype and lower PANSS total and positive scores at baseline (p=0.01; 0.02) and at discharge (p=0.008; 0.005). Covariate analysis revealed a more stable significant association between A-A haplotype and baseline scores. These results suggest a protective effect of A-A haplotype on psychotic positive symptoms at baseline.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18562100     DOI: 10.1016/j.neulet.2008.05.069

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  8 in total

1.  Impaired copper transport in schizophrenia results in a copper-deficient brain state: A new side to the dysbindin story.

Authors:  Kirsten E Schoonover; Stacy L Queern; Suzanne E Lapi; Rosalinda C Roberts
Journal:  World J Biol Psychiatry       Date:  2018-12-20       Impact factor: 4.132

2.  Dysbindin-1A modulation of astrocytic dopamine and basal ganglia dependent behaviors relevant to schizophrenia.

Authors:  Rosa Mastrogiacomo; Gabriella Trigilio; Céline Devroye; Daniel Dautan; Valentina Ferretti; Gabriele Losi; Lucia Caffino; Genny Orso; Roberto Marotta; Federica Maltese; Enrica Vitali; Gessica Piras; Alessia Forgiarini; Giada Pacinelli; Annamaria Lia; Debora A Rothmond; John L Waddington; Filippo Drago; Fabio Fumagalli; Maria Antonietta De Luca; Gian Marco Leggio; Giorgio Carmignoto; Cynthia S Weickert; Francesca Managò; Francesco Papaleo
Journal:  Mol Psychiatry       Date:  2022-07-11       Impact factor: 13.437

3.  Dysbindin-1 in dorsolateral prefrontal cortex of schizophrenia cases is reduced in an isoform-specific manner unrelated to dysbindin-1 mRNA expression.

Authors:  Junxia Tang; Robert P LeGros; Natalia Louneva; Lilly Yeh; Julia W Cohen; Chang-Gyu Hahn; Derek J Blake; Steven E Arnold; Konrad Talbot
Journal:  Hum Mol Genet       Date:  2009-07-19       Impact factor: 6.150

4.  Animal Models of Psychosis: Current State and Future Directions.

Authors:  Alexandra D Forrest; Carlos A Coto; Steven J Siegel
Journal:  Curr Behav Neurosci Rep       Date:  2014-06-01

5.  Abnormalities in the copper transporter CTR1 in postmortem hippocampus in schizophrenia: A subregion and laminar analysis.

Authors:  Kirsten E Schoonover; Charlene B Farmer; Charity J Morgan; Vidushi Sinha; Laura Odom; Rosalinda C Roberts
Journal:  Schizophr Res       Date:  2021-01-09       Impact factor: 4.939

6.  Synaptic dysbindin-1 reductions in schizophrenia occur in an isoform-specific manner indicating their subsynaptic location.

Authors:  Konrad Talbot; Natalia Louneva; Julia W Cohen; Hala Kazi; Derek J Blake; Steven E Arnold
Journal:  PLoS One       Date:  2011-03-01       Impact factor: 3.240

7.  Dysbindin-associated proteome in the p2 synaptosome fraction of mouse brain.

Authors:  Meng-Hsuan J Han; Zhonghua Hu; Cai Yun Chen; Yong Chen; Marjan Gucek; Zheng Li; Sanford P Markey
Journal:  J Proteome Res       Date:  2014-09-19       Impact factor: 4.466

8.  Variations in Dysbindin-1 are associated with cognitive response to antipsychotic drug treatment.

Authors:  Diego Scheggia; Rosa Mastrogiacomo; Maddalena Mereu; Sara Sannino; Richard E Straub; Marco Armando; Francesca Managò; Simone Guadagna; Fabrizio Piras; Fengyu Zhang; Joel E Kleinman; Thomas M Hyde; Sanne S Kaalund; Maria Pontillo; Genny Orso; Carlo Caltagirone; Emiliana Borrelli; Maria A De Luca; Stefano Vicari; Daniel R Weinberger; Gianfranco Spalletta; Francesco Papaleo
Journal:  Nat Commun       Date:  2018-06-11       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.